Injectable Moisturiser vs HA Bio-Remodelling in Singapore: Which Is Better for Hydration, Glow and Skin Quality?

Patients comparing a microdroplet injectable moisturiser with an HA bio-remodelling skin booster are often trying to solve the same broad problem: the skin looks less fresh than it used to. It may be dehydrated, rougher, dull, crepey or less firm, yet the person may not want a conventional volumising filler. Both treatments use hyaluronic acid, but they are not the same injectable and they should not be treated as interchangeable.

The most useful way to compare them is to look at the formulation, injection pattern, treatment objective and clinical evidence rather than asking which brand is simply “better”. The injectable moisturiser is a cross-linked hyaluronic acid microdroplet treatment designed primarily around intradermal hydration and cheek skin smoothness. The HA bio-remodelling treatment uses stable hybrid cooperative complexes of high- and low-molecular-weight hyaluronic acid and is used for broader changes in skin quality, including hydration, elasticity and laxity.

For patients whose main concern is dehydrated-looking, rough or dull skin, an injectable moisturiser in Singapore may fit the treatment goal well. For patients whose concern is broader loss of firmness, elasticity or early laxity, a bio-remodelling HA skin booster may be considered instead. The correct choice depends on the skin in front of the doctor, not on whichever product name is more familiar.

Quick Comparison at a Glance

What Is the Main Difference?

The simplest distinction is treatment emphasis.

The injectable moisturiser is formulated as a smooth, cross-linked hyaluronic acid gel placed as many very small intradermal deposits. The best-supported clinical outcomes are improvement in cheek skin smoothness, fine superficial lines and hydration. In a randomized, multicentre, evaluator-blinded trial, 131 participants received the microdroplet gel (VYC-12L) while 71 were assigned to untreated control. At one month, 57.9% of treated participants met the study definition of a cheek-smoothness responder compared with 4.5% of controls; fine-line responder rates were 58.3% versus 5.4%. Improvements remained evident through six months. [1]

The HA bio-remodelling treatment is different in formulation and concept. It contains stable hybrid cooperative complexes of high- and low-molecular-weight hyaluronic acid. The gel has high tissue diffusivity and is intended to spread through the treated tissue rather than remain as a defined volumising bolus. Published clinical work has examined hydration, elasticity, skin roughness, laxity and other skin-quality measurements. A 2016 open-label study treated 64 women using five predetermined facial injection points on each side, with two sessions four weeks apart, and reported clinical and instrumental improvements through week 16. [2]

This difference matters because “hyaluronic acid injection” is not one single treatment category. Manufacturing changes molecular architecture, rheology, concentration, cohesivity and tissue behaviour. A gel intended to sit as intradermal microdroplets is used differently from one designed for high tissue spread and bio-remodelling, just as both differ from a firmer volumising dermal filler.

Which Is Better for Hydration?

Hydration is a shared benefit, but the evidence is not identical.

The injectable moisturiser has strong direct evidence for increased hydration after intradermal microdroplet placement. In the randomized VYC-12L study, hydration was measured instrumentally alongside cheek smoothness and fine lines. A separate prospective study of 11 volunteers found higher stratum-corneum hydration in treated skin at months 1 and 3, together with changes in firmness and biological markers including aquaporin-3, a membrane channel involved in epidermal water and glycerol transport. [1,3]

Earlier prospective work with VYC-12 also followed 131 participants after intradermal treatment of the cheeks and forehead, with optional neck treatment. Objective measurements showed improvement in skin roughness and hydration, with follow-up extending to nine months. [4] Patient-reported studies also found improvements in how hydrated, refreshed, radiant and healthy the skin looked, although these subjective outcomes should not be confused with an objective hydration measurement. [5]

The HA bio-remodelling treatment also has clinical evidence for hydration. In a 2025 open-label study in Chinese patients, superficial hydration and transepidermal water loss improved over time, with significant changes documented at week 12 versus baseline. [6] A 2026 systematic review identified nine studies involving 278 participants and reported improvements or trends across hydration, elasticity, laxity, density and wrinkle-related outcomes at different anatomical sites. [7]

So the answer to “which hydrates better?” is not a clean head-to-head result. There is no high-quality randomized trial directly comparing the two using the same patient population, treatment area, endpoints and follow-up schedule. What can be said is that the microdroplet treatment has particularly direct evidence around intradermal hydration and cheek smoothness, while the bio-remodelling treatment’s literature evaluates hydration within a broader skin-quality framework.

For someone whose main issue is dehydrated-looking skin, superficial roughness or reduced smoothness without a desire for facial reshaping, the microdroplet concept is closely aligned with that concern. If reduced hydration occurs together with loss of elasticity, crepiness or early laxity, the bio-remodelling treatment may be considered because the goal is broader.

Which Is Better for Firmness, Elasticity and Laxity?

This is where the distinction becomes clearer.

The injectable moisturiser can influence skin quality beyond water content. The small prospective biopsy study reported firmer treated skin that was more resistant to deformation, and histology showed changes in markers associated with epidermal renewal and extracellular-matrix biology. [3] These findings support a biological effect within the skin, but the treatment’s strongest clinical positioning remains smoothness and hydration rather than structural lifting.

The HA bio-remodelling treatment has been studied specifically across outcomes that include elasticity, laxity and density. The early 64-participant study reported improvements in several objective and subjective facial parameters following two treatments. [2] More recent Asian data are relevant to Singapore patients: an open-label Chinese study reported statistically significant improvement in superficial hydration and transepidermal water loss, while a separate real-world survey including patients from Singapore, Malaysia and Indonesia evaluated neck laxity, firmness, tone and texture after two sessions one month apart. [6,8]

That does not mean bio-remodelling should be described as a substitute for a surgical lift, HIFU, radiofrequency treatment or volumising filler. “Bio-remodelling” is a skin-quality concept, not a promise of major tissue repositioning. In a patient with pronounced jowling, deep folds or skeletal or soft-tissue volume loss, neither microdroplet nor standard bio-remodelling treatment may address the primary anatomical problem on its own.

A practical way to think about the comparison is:

• Hydration plus superficial smoothness is the clearest territory for the microdroplet injectable moisturiser.

• Hydration plus elasticity, crepiness or early laxity is more aligned with the broader bio-remodelling approach.

• Volume restoration, projection or contouring belongs to dermal filler or another structural treatment category.

Injection Technique, Number of Points and Treatment Course

The injection pattern is one of the most obvious differences patients notice.

The injectable moisturiser is delivered using multiple small intradermal microdroplets across the treatment area. Expert consensus for VYC-12L has described micro-depot placement in the dermis using small volumes at closely spaced points, with the exact pattern adapted to the treatment area and patient anatomy. [9] The goal is to distribute small amounts through the skin rather than create one or two larger deposits intended to reshape the face.

The bio-remodelling treatment is commonly associated with a predetermined “bio-aesthetic points” approach. In the original facial study, five points were used on each side of the face, with a second treatment four weeks after the first. [2] Different anatomical areas may use different approved or clinician-directed protocols, so patients should not assume that every session involves exactly the same injection map.

The treatment course also differs in practical terms. Microdroplet studies generally assessed one main treatment, with touch-up in some participants when required; in the randomized trial, effectiveness was assessed after the last injection, which could be the initial session or a touch-up. [1] By contrast, many bio-remodelling facial protocols begin with two sessions about one month apart, with maintenance later depending on the individual and treatment plan. [2,6]

This difference is important when comparing price. A single-session price is not necessarily the price of a completed treatment course. Patients should ask whether a quoted price refers to one syringe, one session, one full-face treatment or the entire initial course.

What Results Should You Expect?

The most realistic expectation for either treatment is improvement in skin quality rather than a dramatic change in facial identity.

With the microdroplet injectable moisturiser, the most defensible expectations are smoother cheek skin, increased hydration and improvement in fine superficial lines. In the randomized trial, treated participants had substantially higher one-month responder rates than untreated controls for cheek smoothness and fine lines, and responder rates remained consistent through six months. [1] Participant-reported data from the same programme showed marked improvement in satisfaction with skin and appraisal of lines; most injection-site reactions such as redness, swelling and lumps or bumps resolved within several days. [5]

With the bio-remodelling treatment, the expected outcome is usually described in terms of improved hydration, texture, elasticity, firmness or mild laxity rather than additional cheek projection or contour. The evidence base includes small prospective studies, open-label studies and real-world evaluations. [2,6-8] This evidence is encouraging, but it is less uniform than a single large head-to-head randomized comparison and several studies have industry involvement, which should be kept in mind when interpreting the size and certainty of reported benefits.

Neither treatment should be sold as an instant transformation. Hyaluronic acid begins interacting with tissue and water immediately, but visible skin-quality changes may evolve over days to weeks. Individual response depends on baseline hydration, age, skin thickness, sun damage, smoking, skincare, anatomy and the treatment area.

Downtime and Side Effects

Both treatments involve needle injections, so “zero downtime” is not a medically precise description.

Common short-term effects of intradermal HA injections include redness, swelling, tenderness, bruising and small raised injection-site bumps. In the VYC-12L randomized study, treatment-related adverse events were uncommon and no participant discontinued because of one; participant-reported work found redness, swelling and lumps or bumps to be the most common injection-site reactions, with most resolving within three days. [1,5]

Bio-remodelling studies similarly report temporary local reactions. In the 64-participant open-label study, minor temporary injection-site reactions occurred in 23% of participants. [2] In the more recent Asian neck survey, participants described low-to-moderate pain after injection. [8]

Rare but more serious complications are possible with injectable HA treatments, particularly if material is placed into or compresses a blood vessel. The exact risk profile depends on product properties, injection depth, anatomical area and technique. This is one reason treatment should be performed by a medical practitioner who understands facial anatomy and can assess whether an injectable is appropriate in the first place.

Treatment may need to be postponed in the presence of active infection, inflamed skin or other clinical concerns. A medical consultation should also review previous reactions to injectable treatments, significant allergies, medications that may affect bleeding, and relevant medical conditions.

Which Treatment Suits Different Skin Concerns?

Rather than choosing by age alone, it is more useful to start with the skin problem.

Dehydrated-looking skin, roughness and loss of smoothness: the microdroplet injectable moisturiser may be considered because its clinical programme focuses directly on cheek smoothness, fine lines and hydration.

Dull skin that looks tired despite appropriate topical skincare: the microdroplet treatment may be considered where dehydration and superficial texture are prominent contributors. Pigmentation or vascular redness may require different treatment.

Fine, crepey skin with reduced elasticity: the bio-remodelling treatment may be considered because its literature includes hydration, elasticity, laxity and density outcomes.

Early facial or neck laxity: the bio-remodelling treatment may fit the objective better than a microdroplet hydration treatment, although the degree of laxity matters and other modalities may be more appropriate.

Hollow cheeks, flat midface, weak chin or structural volume loss: neither treatment should automatically be chosen. A structural dermal filler or another treatment may be more appropriate because the primary problem is not simply skin hydration.

Pigmentation, acne scarring, prominent vessels or significant redness: neither is a direct first-line solution for every cause. The diagnosis should come first, followed by a modality targeted to the actual problem.

This is why the comparison should be approached as a clinical matching exercise rather than a popularity contest.

Can the Two Be Combined?

Potentially, but “more injectable” does not automatically mean a better result.

Because the treatments have overlapping but different skin-quality objectives, a doctor may sometimes sequence different modalities in a broader plan.

However, there is limited direct clinical evidence showing that combining them is superior to choosing the more appropriate treatment alone. There is also no reason to duplicate treatment simply because both products contain hyaluronic acid.

A sensible plan starts by identifying the dominant problem: hydration, texture, elasticity, laxity, pigmentation, scarring, volume loss or a combination. If several issues are present, staged treatment can make it easier to judge what is actually working and reduce unnecessary intervention.

How Much Do These Treatments Cost in Singapore?

Prices vary between clinics because the comparison may not be like-for-like. The amount of product used, number of treatment areas, whether touch-up is included, doctor fees and whether the quoted figure is for one session or a full initial course can all change the final cost.

At Nee Soon Clinic, the injectable moisturiser treatment page provides current pricing and treatment details for the microdroplet HA option, while the HA skin-booster (bio-remodelling) page lists its current full-face price. Because clinic prices can change, patients should check the live treatment pages rather than rely on an old article or screenshot.

When comparing prices, ask four questions:

1. How much product is being used?

2. Is the price for one session or the full recommended course?

3. Does the treatment area match between quotes?

4. Is follow-up or a possible touch-up included?

The cheapest single session is not automatically the lowest-cost treatment plan if it requires a different course or does not address the main concern.

What Does the Clinical Evidence Actually Tell Us?

The evidence for both treatments supports improvement in selected skin-quality outcomes, but the quality and design of the evidence are not identical.

The microdroplet gel (VYC-12L) has a notable randomized, multicentre, evaluator-blinded trial with an untreated control group. That design provides stronger causal evidence than an uncontrolled before-and-after study. It demonstrated statistically significant improvement in cheek smoothness and fine lines at one month, with follow-up through six months. [1] Other prospective studies add objective hydration measurements, imaging, histology and patient-reported outcomes. [3-5,10]

The bio-remodelling treatment has a broader but more heterogeneous literature that includes prospective open-label studies, observational studies, Asian patient cohorts and a recent systematic review. [2,6-8] The 2026 systematic review identified improvements or trends in multiple domains but also reflects the limitations of the underlying studies, which vary in body area, outcome measure, follow-up and treatment protocol. Some studies include employees or support from the manufacturer, which does not invalidate the findings but should be disclosed when weighing the evidence.

Most importantly, there is no definitive randomized head-to-head trial proving that one is universally superior to the other. The evidence supports choosing according to treatment objective.

Why Doctor Assessment Matters More Than the Product Name

Aesthetic treatment works best when the diagnosis comes before the product.

Skin can look “tired” because it is dehydrated, but it can also look dull because of pigmentation, photodamage, inflammation, rough surface texture or vascular change. Fine lines can result from dehydration, movement, collagen loss or structural ageing. Apparent laxity may be true skin laxity, volume loss, ligamentous change or a combination.

Two patients asking for “more glow” may therefore need completely different treatment plans.

A doctor-led consultation should assess skin quality, facial anatomy, medical history, previous injectables, allergies, medications and the patient’s actual priorities. The treatment should then be matched to the problem rather than forcing every concern into the same injectable category.

Frequently Asked Questions

Are they the same treatment?

No. Both contain hyaluronic acid, but the formulations, tissue behaviour, injection pattern and treatment objectives differ. The microdroplet injectable moisturiser has strong evidence for cheek smoothness and hydration. The bio-remodelling treatment uses hybrid cooperative complexes of high- and low-molecular-weight HA and is used as a broader skin-quality treatment.

Which is better for glow?

“Glow” is subjective and can reflect hydration, smoothness, pigmentation, circulation and light reflection from the skin surface. The microdroplet treatment has patient-reported data showing improved satisfaction with radiance and hydration, while bio-remodelling studies report improvements in hydration and broader skin-quality measures. The better choice depends on why the skin looks dull.

Which is better for dry skin?

True dry skin and dehydrated skin are not identical. Dry skin is often a barrier or oil issue and may respond primarily to skincare changes. Injectable HA is more relevant when lack of water within the skin and reduced skin quality are part of the problem. A doctor should distinguish the two before recommending an injection.

Which is better for loose skin?

For mild loss of elasticity or early laxity, the bio-remodelling treatment is more closely aligned with that objective. Significant laxity may need energy-based treatment, surgery or another approach. The microdroplet treatment is not primarily a lifting treatment.

Does the microdroplet treatment add volume like filler?

Its objective is skin smoothness and hydration rather than intentional facial reshaping. Small intradermal microdroplets are distributed through the skin. A conventional volumising filler uses different rheological properties, injection planes and quantities to provide structure or contour.

How many sessions are needed?

Microdroplet studies commonly involved one primary treatment with touch-up when needed. Many bio-remodelling protocols use an initial two-session course about four weeks apart. The exact plan should be individualised and may differ by area, baseline skin and response.

How long do the effects last?

Studies of the microdroplet gel (VYC-12L) have followed skin-quality improvements through six months, and other prospective work has followed hydration and patient-reported outcomes for longer. Bio-remodelling studies report measurable improvement for several months, but duration varies by endpoint and protocol. Maintenance is individualised rather than fixed for every patient.

Can I choose based on price alone?

It is better to compare the complete treatment plan. A lower per-session price may not be cheaper if a different number of sessions, syringes or maintenance visits is needed. More importantly, a treatment that does not match the problem is poor value at any price.

References

[1] Alexiades M, Palm MD, Kaufman-Janette J, et al. A Randomized, Multicenter, Evaluator-blind Study to Evaluate the Safety and Effectiveness of VYC-12L Treatment for Skin Quality Improvements. Dermatologic Surgery. 2023;49(7):682-688. PMID 37163665.

[2] Sparavigna A, Tenconi B. Efficacy and tolerance of an injectable medical device containing stable hybrid cooperative complexes of high- and low-molecular-weight hyaluronic acid: a monocentric 16-week open-label evaluation. Clin Cosmet Investig Dermatol. 2016;9:297-305. PMID 27713647.

[3] Safa M, et al. A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers. Clin Cosmet Investig Dermatol. 2022;15:411-426. PMID 35300433.

[4] Niforos F, et al. VYC-12 Injectable Gel Is Safe and Effective for Improvement of Facial Skin Topography: A Prospective Study. Clin Cosmet Investig Dermatol. 2019. PMID 31749628.

[5] Chiu A, Montes JR, Munavalli G, et al. Improved Patient Satisfaction With Skin After Treatment of Cheek Skin Roughness and Fine Lines With VYC-12L. Aesthet Surg J. 2023;43(11):1367-1375. PMID 37074002.

[6] Efficacy and Tolerability of Stable Hybrid Cooperative Complexes of High- and Low-Molecular-Weight Hyaluronic Acid in Asian Patients: An Open-Label Study. 2025. PMID 40921777.

[7] A Systematic Review of the Efficacy and Safety of Profhilo and Profhilo Body. 2026. PMID 41920062.

[8] Patient Satisfaction Using Hybrid Cooperative Complexes of Hyaluronic Acid for Neck Laxity: A Survey of Asian Populations. PMID 40627798.

[9] Expert Consensus on Injection Technique and Area-Specific Recommendations for the Hyaluronic Acid Dermal Filler VYC-12L to Treat Fine Cutaneous Lines. PMID 32308460.

[10] Ogilvie P, et al. Skin Quality Improvement With VYC-12, a New Injectable Hyaluronic Acid: Objective Results Using Digital Analysis. Dermatologic

Surgery. 2019. PMID 30893167.

Official reference links: https://www.skinvivebyjuvederm.com/ and https://profhilo.com.sg/

Disclaimer:The information provided in this article is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. The content is not intended to be a comprehensive source of information and should not be relied upon as such. Reliance on any information provided in this article is solely at your own risk. The authors and the publisher do not endorse or recommend any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned in the article. Any reliance on the information in this article is solely at the reader's own risk.